We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMAR icon
7501
Innovator US Equity Power Buffer ETF March
PMAR
$770M
$34.7K ﹤0.01%
864
-17,575
-95% -$699K
FYBR
7502
CALL
DELISTED
Frontier Communications
FYBR
$34.7K ﹤0.01%
+1,000
New +$35.1K
BLDG icon
7503
Cambria Global Real Estate ETF
BLDG
$66M
$34.6K ﹤0.01%
+1,371
New +$36.2K
STEX
7504
Streamex Corp
STEX
$75.3M
$34.5K ﹤0.01%
+23,121
New +$35.2K
PULM icon
7505
Pulmatrix
PULM
$6.06M
$34.3K ﹤0.01%
4,920
+4,528
+1,155% +$18.7K
GDTC icon
7506
CytoMed Therapeutics
GDTC
$9.5M
$34.3K ﹤0.01%
10,098
+10,037
+16,454% +$24.1K
CLIR icon
7507
ClearSign Technologies
CLIR
$26.1M
$34.3K ﹤0.01%
2,383
+1,389
+140% +$13.7K
FACTU
7508
FACT II Acquisition Corp Unit
FACTU
$34.2K ﹤0.01%
+3,431
New +$34.2K
PLX icon
7509
Protalix BioTherapeutics
PLX
$197M
$34.2K ﹤0.01%
18,178
+17,886
+6,125% +$25.3K
AENT icon
7510
Alliance Entertainment
AENT
$290M
$34K ﹤0.01%
3,754
+3,102
+476% +$14.7K
TKLF
7511
Yoshitsu Co
TKLF
$8.17M
$34K ﹤0.01%
10,267
-2,956
-22% -$12.3K
FJUN icon
7512
FT Vest US Equity Buffer ETF June
FJUN
$1.39B
$34K ﹤0.01%
661
PRT
7513
PermRock Royalty Trust Unit
PRT
$27.4M
$33.9K ﹤0.01%
+9,641
New +$37.1K
MVO
7514
DELISTED
MV Oil Trust
MVO
$33.9K ﹤0.01%
4,219
-12,608
-75% -$112K
GMNY
7515
Goldman Sachs Dynamic New York Municipal Income ETF
GMNY
$39.7M
$33.8K ﹤0.01%
+680
New +$34.2K
SGRP
7516
DELISTED
SPAR Group
SGRP
$33.7K ﹤0.01%
17,381
+17,379
+868,950% +$38.9K
BBLU icon
7517
EA Bridgeway Blue Chip ETF
BBLU
$458M
$33.7K ﹤0.01%
+2,579
New +$33.8K
FLGV icon
7518
Franklin US Treasury Bond ETF
FLGV
$1.03B
$33.5K ﹤0.01%
+1,666
New +$34.1K
AP icon
7519
Ampco-Pittsburgh
AP
$193M
$33.4K ﹤0.01%
16,000
MCSE
7520
DELISTED
Franklin Sustainable International Equity ETF
MCSE
$33.4K ﹤0.01%
2,538
+2,441
+2,516% +$34.2K
AVXC icon
7521
Avantis Emerging Markets ex-China Equity ETF
AVXC
$399M
$33.3K ﹤0.01%
+673
New +$35.1K
JUCY icon
7522
Aptus Enhanced Yield ETF
JUCY
$317M
$33.3K ﹤0.01%
1,464
+1,207
+470% +$27.8K
HPAI
7523
Helport AI
HPAI
$17.5M
$33.1K ﹤0.01%
5,963
+4,199
+238% +$22.8K
FUSB icon
7524
First US Bancshares
FUSB
$92.2M
$33.1K ﹤0.01%
+2,628
New +$32.7K
MNSB icon
7525
MainStreet Bancshares
MNSB
$171M
$33.1K ﹤0.01%
1,828
+1,779
+3,631% +$32.6K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.